Advent-controlled Suven Pharma appoints former Piramal exec as chairman
Private equity firm Advent International-controlled Suven Pharmaceuticals Ltd has appointed former Piramal Pharma Solutions Ltd’s chief executive officer Vivek Sharma as its new executive chairman with immediate effect. Sharma succeeds Annaswamy Vaidheesh, who is transitioning from the board to serve as vice-chair of Suven’s Advisory Council, the Hyderabad-based drugmaker said in ......
Advent eyes benchmark returns from second portfolio exit in 2024
Global private equity firm Advent International, which has been active in India this year having struck an exit from Bharat Serums and making fresh bets in two companies, is now looking to hit the sell button on a portfolio company through an initial public offering. The US-based PE firm intends to partially ......
Grapevine: TPG may lead edtech firm’s funding; Advent mulls Manjushree monetisation
Eruditus, an Indian edtech startup, is nearing a $150 million funding round led by TPG, a media report said. This would be the largest fundraising by an Indian education firm in recent years. The new investment could value Eruditus at up to $2.3 billion, contingent on achieving performance targets, Techcrunch reported, ......
ADIA teams up with Advent International to buy into US money manager
Fisher Investments on Sunday said U.S.-based private equity firm Advent International and a unit of the Abu Dhabi Investment Authority (ADIA) have agreed to acquire a minority stake in the money-management firm valuing it at $12.75 billion. Fisher Investments said the investment will be in the range of $2.5 billion to ......
Mankind Pharma to buy Bharat Serums as Advent International exits
Mankind Pharma Ltd has agreed to acquire Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise value of about Rs 13,630 crore ($1.63 billion). The move marks a "significant leap" for Mankind Pharma, positioning it as a market leader in the Indian women's health and ......
Advent International to invest $296 mn in Apollo Hospital unit
US-based private equity firm Advent International has agreed to invest Rs 2,475 crore ($296 million) to pick up a minority stake in Apollo HealthCo Ltd, a subsidiary of Apollo Hospitals Enterprise Ltd. The transaction would enable the merger of two units under Apollo Healthco—wholesale pharma distribution vertical Keimed Pvt Ltd and ......
Exclusive: PE-backed platforms in fray for API maker Aurore Life
Hyderabad-based bulk-drugs maker Aurore Life Sciences has attracted interest from a number of suitors, including pharmaceutical platforms formed by private equity firms, three people aware of the development told VCCircle. The development comes three years after Aurore decided to merge with Solara Active Pharma Sciences Ltd and two years after the ......
Exclusive: Advent’s healthcare investment platform mulls betting on south Indian API maker
Advent, one of the world’s biggest private equity players, is evaluating an investment in a Chennai-based active pharmaceutical ingredient (API) company through its pharma platform Cohance, three people aware of the development told VCCircle on condition of anonymity. The PE firm, which rebranded its API and CDMO platform to Cohance in ......
Indian, global PE firms plan food service platforms, encircle QSR players
A number of foreign and Indian private equity firms are approaching quick-service restaurant (QSR) brands in several categories as they explore the possibility of separately creating food service platforms in the country, three people aware of the developments told VCCircle. The PE firms are likely to invest in larger brands to ......
Grapevine: PEs, others eye Theobroma; layoffs lead to closure murmur at ReshaMandi
At least four entities, including Switz Group and private equity firms Kedaara Capital, Carlyle, and ChrysCapital, have submitted non-binding bids for a majority stake in Indian bakery chain Theobroma, a media report said. VCCircle first reported that US investment giant Carlyle Group, US-based General Atlantic, Advent International, and India’s ChrysCapital are evaluating investing in the bakery chain. Non-binding bids were submitted ......